Persberichten
2005
31/08/2005
ABLYNX SUCCESSFULL IN MAINTAINING KEY CLAIMS AFTER NANOBODY™ PATENT CHALLENGE
18/08/2005
ABLYNX APPOINTS HENNIE HOOGENBOOM AS CHIEF SCIENTIFIC OFFICER
18/08/2005
SCIENTIFIC AMERICAN REVIEWS THE POTENTIAL OF ABLYNX'S NANOBODIES AS DRUGS